Human Peripheral Blood Mononuclear Cells Exhibit Heterogeneous CD52 Expression Levels and Show Differential Sensitivity to Alemtuzumab Mediated Cytolysis

Alemtuzumab is a monoclonal antibody that targets cell surface CD52 and is effective in depleting lymphocytes by cytolytic effects in vivo. Although the cytolytic effects of alemtuzumab are dependent on the density of CD52 antigen on cells, there is scant information regarding the expression levels...

Descripción completa

Detalles Bibliográficos
Autores principales: Rao, Sambasiva P., Sancho, Jose, Campos-Rivera, Juanita, Boutin, Paula M., Severy, Peter B., Weeden, Timothy, Shankara, Srinivas, Roberts, Bruce L., Kaplan, Johanne M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3382607/
https://www.ncbi.nlm.nih.gov/pubmed/22761788
http://dx.doi.org/10.1371/journal.pone.0039416

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3382607/
https://www.ncbi.nlm.nih.gov/pubmed/22761788
http://dx.doi.org/10.1371/journal.pone.0039416

Ejemplares similares